» Authors » Margherita Melegari

Margherita Melegari

Explore the profile of Margherita Melegari including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 590
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao C, Melegari M, Philippi M, Domaretskiy D, Ubrig N, Gutierrez-Lezama I, et al.
Adv Mater . 2023 Feb; 35(18):e2211993. PMID: 36812653
Ionic gating is a powerful technique to realize field-effect transistors (FETs) enabling experiments not possible otherwise. So far, ionic gating has relied on the use of top electrolyte gates, which...
2.
Farronato M, Mannocci P, Melegari M, Ricci S, Compagnoni C, Ielmini D
Adv Mater . 2022 Oct; 35(37):e2205381. PMID: 36222391
Novel memory devices are essential for developing low power, fast, and accurate in-memory computing and neuromorphic engineering concepts that can compete with the conventional complementary metal-oxide-semiconductor (CMOS) digital processors. 2D...
3.
Bartolacci C, Andreani C, Vale G, Berto S, Melegari M, Crouch A, et al.
Nat Commun . 2022 Aug; 13(1):4640. PMID: 35941179
No abstract available.
4.
Bartolacci C, Andreani C, Vale G, Berto S, Melegari M, Crouch A, et al.
Nat Commun . 2022 Jul; 13(1):4327. PMID: 35882862
Mutant KRAS (KM), the most common oncogene in lung cancer (LC), regulates fatty acid (FA) metabolism. However, the role of FA in LC tumorigenesis is still not sufficiently characterized. Here,...
5.
Constanzo J, Tang K, Rindhe S, Melegari M, Liu H, Tang X, et al.
Neoplasia . 2019 Jul; 18(7):457. PMID: 31265543
[This corrects the article DOI: 10.1016/j.neo.2016.03.003.].
6.
Padanad M, Konstantinidou G, Venkateswaran N, Melegari M, Rindhe S, Mitsche M, et al.
Cell Rep . 2016 Aug; 16(6):1614-1628. PMID: 27477280
KRAS is one of the most commonly mutated oncogenes in human cancer. Mutant KRAS aberrantly regulates metabolic networks. However, the contribution of cellular metabolism to mutant KRAS tumorigenesis is not...
7.
Rabellino A, Melegari M, Tompkins V, Chen W, Van Ness B, Teruya-Feldstein J, et al.
Cell Rep . 2016 May; 15(10):2266-2278. PMID: 27239040
The MYC proto-oncogene is a transcription factor implicated in a broad range of cancers. MYC is regulated by several post-translational modifications including SUMOylation, but the functional impact of this post-translational...
8.
Constanzo J, Tang K, Rindhe S, Melegari M, Liu H, Tang X, et al.
Neoplasia . 2016 May; 18(5):282-293. PMID: 27237320
The sequence of genomic alterations acquired by cancer cells during tumor progression and metastasis is poorly understood. Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that integrates cytoskeleton remodeling,...
9.
Tang K, Constanzo J, Venkateswaran N, Melegari M, Ilcheva M, Morales J, et al.
Clin Cancer Res . 2016 May; 22(23):5851-5863. PMID: 27220963
Purpose: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide due to the limited availability of effective therapeutic options. For instance, there are no effective strategies...
10.
Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant B, Slagle B, et al.
Am J Pathol . 2008 Aug; 173(3):856-64. PMID: 18688024
Alterations in microRNA (miRNA) expression in both human and animal models have been linked to many forms of cancer. Such miRNAs, which act directly as repressors of gene expression, have...